Mechanistic Inferences from the Crystal Structure of Fumarylacetoacetate Hydrolase with a Bound Phosphorus-based Inhibitor
Open Access
- 1 January 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (18), 15284-15291
- https://doi.org/10.1074/jbc.m007621200
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cyclin B‐dependent kinase and caspase‐1 activation precedes mitochondrial dysfunction in fumarylacetoacetate‐induced apoptosisThe FASEB Journal, 1999
- Complete Rescue of Lethal Albino c Mice by Null Mutation of 4-Hydroxyphenylpyruvate Dioxygenase and Induction of Apoptosis of Hepatocytes in These Mice by in VivoRetrieval of the Tyrosine Catabolic PathwayJournal of Biological Chemistry, 1997
- The Mutagenicity of the Tyrosine Metabolite, Fumarylacetoacetate, Is Enhanced by Glutathione DepletionBiochemical and Biophysical Research Communications, 1997
- Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type INature Genetics, 1995
- Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenaseThe Lancet, 1992
- Deficiency of an enzyme of tyrosine metabolism underlies altered gene expression in newborn liver of lethal albino mice.Genes & Development, 1992
- Neurologic Crises in Hereditary TyrosinemiaNew England Journal of Medicine, 1990
- Chromosomal Instability in Hereditary Tyrosinemia Type IPediatric Pathology, 1990
- Biochemical Studies of a Patient with Hereditary Hepatorenal Tyrosinemia: Evidence of Glutathione DeficiencyPediatric Research, 1984
- On the enzymic defects in hereditary tyrosinemia.Proceedings of the National Academy of Sciences, 1977